Compared to the control group, the NAFLD group showed significant upregulation of TC, TG, LDL‐C, ALT, AST, CREA, and BUN (p < 0.01), whereas HDL‐C levels decreased significantly in the NAFLD group (p < 0.01) (Figure 1G–N). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.